PD research: main takeaways from 2021 and... - Cure Parkinson's

Cure Parkinson's

26,183 members27,513 posts

PD research: main takeaways from 2021 and results to be looking for in 2022 by Dr Simon Stott

Michel0220 profile image
0 Replies

Just a little reminder that our next speaker is on 10th January at 7.30 pm (London time).

Dr. Simon Stott is Deputy Director of Research for Cure Parkinson's with 20 years of experience in both academic and biotech sectors.

He will be reviewing the research from 2021 and looking at what we can expect in 2022.

Please follow this link to register for this free event:-

eventbrite.co.uk/e/pd-resea...

Simon also manages an excellent website called "The Science of Parkinson's", offering plain English explanations of current research, so take a look here: scienceofparkinsons.com.

We look forward to you joining us and please share this invitation with anyone else that you feel might benefit from the information

Written by
Michel0220 profile image
Michel0220
To view profiles and participate in discussions please or .

Not what you're looking for?

You may also like...

PD research: main takeaways from 2021 and results to be looking for in 2022 by Dr Simon Stott

I am delighted to announce that our next zoom session will be taking place at 7.30 pm London time...

The recording of "PD research takeaways from 2022 and research results to be looking for in 2023" by Dr Simon Stott is now available

Thank you to those of you who joined us on 10th Jan to listen to the presentation by Dr. Simon...

Recording now available for NoSilverBullet/Cure Parkinson’s presentation by Dr Simon Stott on his main PD research takeaways from 2023/24

We were delighted to host Dr. Simon Stott again in what is becoming our regular start to the year's...

Dr. Simon Stott's recording is now available- PD research round up 2021 & looking ahead to 2022

Thank you to all of you who joined us on Monday. We had some wonderful feedback on Simon's...

Light Therapy Clinical Trial

For those who might be interested, I received the message below from PhotoPharmics today providing...